Luke S. Mclean

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Cemiplimab in the treatment of cutaneous squamous cell carcinoma.

Cemiplimab in the treatment of cutaneous squamous cell carcinoma.

Journal: Immunotherapy

Published: January 29, 2026

BRAF-targeted therapy in non-melanomatous BRAF-mutant tumours: a systematic review of broad but histology-modulated efficacy.

BRAF-targeted therapy in non-melanomatous BRAF-mutant tumours: a systematic review of broad but histology-modulated efficacy.

Journal: International journal of clinical oncology

Published: January 07, 2026

Extended follow-up outcomes of patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab on EMPOWER-CSCC-1: A retrospective cohort study.

Extended follow-up outcomes of patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab on EMPOWER-CSCC-1: A retrospective cohort study.

Journal: Journal of the American Academy of Dermatology

Published: June 19, 2025

Optimising Patient Outcomes in Tongue Cancer: A Multidisciplinary Approach.

Optimising Patient Outcomes in Tongue Cancer: A Multidisciplinary Approach.

Journal: Cancers

Published: March 07, 2024

A Retrospective Review and Comprehensive Tumour Profiling of Advanced Non-Melanomatous Cutaneous Spindle Cell Neoplasms Treated with Immune-Checkpoint Inhibitors.

A Retrospective Review and Comprehensive Tumour Profiling of Advanced Non-Melanomatous Cutaneous Spindle Cell Neoplasms Treated with Immune-Checkpoint Inhibitors.

Journal: Cancers

Published: January 25, 2024

Real-World Experience of Immune-Checkpoint Inhibitors in Older Patients with Advanced Cutaneous Squamous Cell Carcinoma.

Real-World Experience of Immune-Checkpoint Inhibitors in Older Patients with Advanced Cutaneous Squamous Cell Carcinoma.

Journal: Drugs & aging

Published: December 30, 2023

Assessment of perineural spread in advanced cutaneous squamous cell carcinomas treated with immunotherapy.

Assessment of perineural spread in advanced cutaneous squamous cell carcinomas treated with immunotherapy.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: October 19, 2023

Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study.

Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study.

Journal: The Medical journal of Australia

Published: May 11, 2023

In-transit cutaneous squamous cell carcinoma.

In-transit cutaneous squamous cell carcinoma.

Journal: The Medical journal of Australia

Published: March 31, 2022

A phase II study of tarloxotinib (a hypoxia activated prodrug of a pan-erb tyrosine kinase inhibitor) in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or skin.

A phase II study of tarloxotinib (a hypoxia activated prodrug of a pan-erb tyrosine kinase inhibitor) in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or skin.

Journal: Investigational new drugs

Published: January 07, 2022

Standard-Dose Osimertinib in EGFR-Mutated Non-Small-Cell Lung Adenocarcinoma With Leptomeningeal Disease.

Standard-Dose Osimertinib in EGFR-Mutated Non-Small-Cell Lung Adenocarcinoma With Leptomeningeal Disease.

Journal: JCO precision oncology

Published: January 07, 2022

Immunotherapy to Avoid Orbital Exenteration in Patients With Cutaneous Squamous Cell Carcinoma.

Immunotherapy to Avoid Orbital Exenteration in Patients With Cutaneous Squamous Cell Carcinoma.

Journal: Frontiers in oncology

Published: October 16, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026